Literature DB >> 7532399

Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells.

V Gebuhrer1, J F Murphy, J C Bordet, M P Reck, J L McGregor.   

Abstract

It is now well established that monocytes adhere to endothelial cells activated by oxidized low-density lipoproteins (LDL). However, the adhesive receptors on endothelial cells involved in binding monocytes, following an insult by oxidized LDL, remains to be elucidated. In this study we have looked at the effect of native or oxidized LDL on the expression of P-selectin. Native LDL (N-LDL) was oxidized by incubation with either endothelial cells (EC-LDL) or copper (Cu-LDL), or in culture medium as a control (C-LDL). Expression of P-selectin was assayed with an anti-P-selectin (CD62) monoclonal antibody (LYP20). Results show that EC-LDL and Cu-LDL, but not N-LDL or C-LDL, induce the expression of P-selectin by human umbilical-vein endothelial cells (HUVECs). Induction of P-selectin by low concentrations (20 micrograms/ml) of LDL is directly related to the state of oxidation of the LDL particles. In addition, high concentrations (100 micrograms/ml) of N-LDL also activate HUVECs by inducing P-selectin expression. This expression was sustained for a period of over 1 h on LDL-activated endothelial cells, in contrast with thrombin- or histamine-activated endothelial cells, whose P-selectin levels fall within 15-20 min after induction. E-selectin, in contrast with P-selectin, could not be induced by endothelial cells treated with low or high concentrations of oxidized LDL. Results in this study show that P-selectin expressed by oxidized-LDL-treated endothelial cells are involved in mediating the adhesion of a monocytic cell line (U937) or monocytes in peripheral-blood mononuclear cells. An anti-P-selectin monoclonal antibody (LYP20) inhibited the binding of U937 cells and monocytes. These results strongly suggest that P-selectin is involved in the early stages of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532399      PMCID: PMC1136515          DOI: 10.1042/bj3060293

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 2.  The low-density lipoprotein pathway and its relation to atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.

Authors:  C P Sparrow; S Parthasarathy; D Steinberg
Journal:  J Lipid Res       Date:  1988-06       Impact factor: 5.922

5.  The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex.

Authors:  T J Kunicki; D J Nugent; S J Staats; R P Orchekowski; E A Wayner; W G Carter
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

6.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Authors:  T E Carew; D C Schwenke; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells.

Authors:  J F Murphy; J C Bordet; B Wyler; M C Rissoan; P Chomarat; T Defrance; P Miossec; J L McGregor
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro.

Authors:  G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

View more
  10 in total

Review 1.  Platelet-endothelial interactions in atherosclerosis.

Authors:  B S Sachais
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

2.  Absence of P-selectin delays fatty streak formation in mice.

Authors:  R C Johnson; S M Chapman; Z M Dong; J M Ordovas; T N Mayadas; J Herz; R O Hynes; E J Schaefer; D D Wagner
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

3.  Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin.

Authors:  P T Shih; M J Elices; Z T Fang; T P Ugarova; D Strahl; M C Territo; J S Frank; N L Kovach; C Cabanas; J A Berliner; D K Vora
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 4.  Monocyte-endothelial cell interactions in the development of atherosclerosis.

Authors:  Javier Mestas; Klaus Ley
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

5.  P-selectin gene polymorphisms and risk of coronary heart disease among Tunisians.

Authors:  Lakhdar Ghazouani; Nesrine Abboud; Sonia Bel-Hadj Khlifa; Claire Perret; Viviane Nicaud; François Cambien; Wassim Y Almawi; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2008-12-11       Impact factor: 2.300

6.  Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.

Authors:  Hiroyuki Oka; Satoshi Ikeda; Seiji Koga; Yoshiyuki Miyahara; Shigeru Kohno
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

7.  Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells.

Authors:  Chong Chen; Damir B Khismatullin
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

8.  Coriandrum sativum L. seed extract mitigates lipotoxicity in RAW 264.7 cells and prevents atherogenic changes in rats.

Authors:  Dipak Patel; Swati Desai; Tejal Gajaria; Ranjitsinh Devkar; A V Ramachandran
Journal:  EXCLI J       Date:  2013-04-10       Impact factor: 4.068

9.  Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients.

Authors:  Qiu Tang; Qiao-Ying Hu; Yong-Feng Piao; Yong-Hong Hua
Journal:  Onco Targets Ther       Date:  2016-05-02       Impact factor: 4.147

10.  The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke.

Authors:  Malgorzata Pawelczyk; Beata Kaczorowska; Zbigniew Baj
Journal:  Arch Med Sci       Date:  2017-02-01       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.